
Covalon Investor Relations Material
Latest events

Q1 2025
Covalon
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Covalon Technologies Ltd
Access all reports
Covalon Technologies Ltd. is a medical technology company that develops, manufactures, and markets advanced wound care products, infection prevention solutions, and medical devices. The company's product offerings include antimicrobial dressings, collagen-based wound care products, and adhesive technologies designed to reduce infections and improve patient outcomes. Covalon serves healthcare providers, hospitals, and long-term care facilities, with a focus on providing solutions that promote faster healing and reduce the risk of complications in patients. The company operates primarily in North America and internationally, addressing the needs of the healthcare and medical device industries. The company is headquartered in Mississauga, Ontario, Canada, and its shares are listed on the TSX.
Key slides for Covalon Technologies Ltd


Q3 2024
Covalon Technologies Ltd


Q1 2025
Covalon Technologies Ltd
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
COV
Country
🇨🇦 Canada